Cargando…
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review
Toll-like receptors 3 (TLR3) have been broadly studied among all TLRs over the last few decades together with its agonists due to their contribution to cancer regression. These agonists undeniably have some shared characteristics such as mimicking dsRNA but pathways through which they exhibit antitu...
Autores principales: | Komal, Asma, Noreen, Mamoona, El-Kott, Attalla F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213534/ https://www.ncbi.nlm.nih.gov/pubmed/34145551 http://dx.doi.org/10.1007/s12026-021-09203-6 |
Ejemplares similares
-
Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
por: Naumann, Kai, et al.
Publicado: (2013) -
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair
por: Natarajan, Chandramohan, et al.
Publicado: (2016) -
Vaccine immunotherapy with ARNAX induces tumor‐specific memory T cells and durable anti‐tumor immunity in mouse models
por: Takeda, Yohei, et al.
Publicado: (2018) -
The Response of Tissue Mast Cells to TLR3 Ligand Poly(I:C) Treatment
por: Witczak, Piotr, et al.
Publicado: (2020) -
IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner
por: Chiba, Yukino, et al.
Publicado: (2013)